SCHEMBL1324397

SCHEMBL1324397

O=C(/C=C/c1ccc(Br)cc1)NS(=O)(=O)/C=C/c1ccc(Br)cc1.O=S(=O)(/C=C\c1ccc(Br)cc1)NS(=O)(=O)/C=C/c1ccc(Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
LMNA P02545 4/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
TRPA1 O75762 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
PTGES2 Q9H7Z7 1/20 0.43
SLC5A1 P13866 1/20 0.42
SLC5A2 P31639 1/20 0.42
KDM4E B2RXH2 2/20 0.42
PLAAT3 P53816 1/20 0.42
PLAAT5 Q96KN8 1/20 0.42
PLAAT2 Q9NWW9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1324399 1.00 CYP1A2 (0.46) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1323451 0.95 CYP1A2 (0.49) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1324735 0.95 CYP1A2 (0.49) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1323598 0.95 CYP1A2 (0.49) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1323452 0.95 CYP1A2 (0.49) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1324751 0.85 HDAC2 (0.53) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1324636 0.85 CA12 (0.49) LMNAPOLBTRPA1SLC5A1SLC5A2
SCHEMBL1324753 0.85 HDAC2 (0.53) CYP1A2LMNARAB9ASMN1; SMN2NPC1
SCHEMBL1324278 0.85 HDAC1 (0.39) LMNAKMT2AHDAC3HDAC4HDAC1
SCHEMBL1324281 0.85 HDAC1 (0.39) LMNAKMT2AHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058313-B2 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases Temple University—Of the Commonwealth System of Higher Education (US) 2011-11-15 US claimed